Jafar Jamil Abunasser

Jafar Abunasser practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Jafar Abunasser's NPI, 1093914327, was assigned on July 17, 2007. Jafar Abunasser holds Texas license P7235.

Jafar Abunasser's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Jafar Abunasser's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. The medical group on file is Cleveland Clinic. Dmand AI also links Jafar Abunasser to 2 more clinical labs and 2 medical groups, each named with a free account. Jafar Abunasser's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Jafar Abunasser practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Jafar Abunasser's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Jafar Abunasser's licenses on file in 2 states: Texas and Ohio.

CMS data shows 487 Medicare services from Jafar Abunasser across 5 procedure codes in 2024, for 113 Medicare patients. Medicare paid $34,592 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 113 Medicare patients who saw Jafar Abunasser in 2024. The largest group is 65 to 74, with 45 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 4.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Jafar Abunasser's median patient age at 63, with 52% women.

In 2017, Jafar Abunasser wrote 32 Medicare Part D claims. They cover 2 drugs, with $13,077 in total drug cost.

Jafar Abunasser accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 25 general payments to Jafar Abunasser from 15 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 87% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $116.